The White House is reviewing three top contenders for the position of FDA commissioner, according to STAT News. The outlets describe the finalists as being under consideration, with the review process still ongoing. The timing of the decision is described as highly anticipated, and the reporting indicates the White House may reach a conclusion soon. The sources do not specify which candidates are in contention or provide details about the administration’s criteria for selection. They also do not describe any confirmed outcome or appointment date. Overall, the information centers on the current status of the selection process: the White House is vetting several leading finalists before selecting a candidate to lead the U.S. Food and Drug Administration. Until a decision is announced through formal channels, the identity of the commissioner and the start date for the new leadership remain uncertain. The reporting characterizes the review as the final stage before an expected announcement.